In mid-2015 Baxter will split into two companies. One will focus on medical products for healthcare solutions; the other on developing and marketing biopharmaceuticals.
On March 9, there was an anniversary   Read More

“In the stock market — or in any widely traded market — there’s an inevitable fact of life: bear markets happen. It’s a topic I’d just as soon avoid. After   Read More

This advisory is dropping American Express Co. (AXP-NYSE, $75.64) from its “buy” list. Yes, its shares are yelling “charge it!” (they’re up 29 per cent this year) and running ahead   Read More